U.S. Pharmaceutical Supply Chain Consultant
The COVID pandemic highlighted the importance of pharmaceutical supply chain and encouraged multiple countries to seek to increase supply chain security by increasing the domestic production of essential pharmaceutical commodities. It also highlighted the need for more visibility into the risks in and resilience of the upstream pharmaceutical supply chain. In the United States, the Trump administration committed to and initiated investment towards increasing domestic medicines manufacturing, and the Biden administration appears to have committed to this approach as well as to taking additional measures to improve supply chain security.
To feasibly domesticate manufacturing in the U.S. market and further secure the domestic supply of essential medicines, new technologies and approaches are being adopted, and multiple enabling factors and shared services for these manufacturers are required.
USP has a critical role to play in advancing supply chain security by increasing visibility into the risk and resilience of the upstream supply chain and enabling adoption of innovative manufacturing approaches through its standard-setting, scientific and related programs.
SCOPE OF WORK
USP is seeking an individual or firm who understand USG and state-based funding opportunities and underlying drivers/ priorities pertaining to identifying, characterizing, quantifying risk in the upstream supply chain and securing the domestic supply of pharmaceutical commodities. This could be agencies with a mandate to procure pharmaceutical commodities and/ or broader mandate to secure domestic supply chain (such as by increasing visibility into the upstream supply chain or through investment in domestication of pharmaceutical manufacturers). For example, DoD, BARDA, CMS, NIH etc.
The consultancy is envisioned to last 3-months and would include developing a baseline understanding of where:
1) USP could contribute to these priorities and
2) delineation of USG entities investing in or with the potential to invest in this space, including:
a) Identification of all relevant agencies
b) Outline of agency priorities
c) Mapping of historic funding streams, current opportunities, and possible future opportunities
d) Development of proposed pathway to engage relevant agencies in exploratory conversations
e) Identification of potential partners with whom USP can work in pursuing opportunities
APPLICATION SUBMISSION REQUIREMENTS
Please send a CV to huyliem.nguyen@USP.org by February 23, 2021. Please write “U.S. Pharmaceutical Supply Chain Consultant” in the subject line of the application e-mail.
The U.S. Pharmacopeial Convention (USP) is an independent, scientific nonprofit organization focused on building trust in the supply of safe, quality medicines. We are working to strengthen the global supply chain so that the medicines people rely on for health are available when needed and work as expected. USP’s Global Health programs works with donors and partners in low- and middle-income countries to advance access to quality-assured essential medicines and strengthen supply chains to address critical global health threats such as COVID-19, tuberculosis, HIV and AIDS, and maternal and child health conditions.
